Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccinia Virus
Findings from Imperial College London, Department of Virology provide new insights into vaccinia virus
January 7th, 2009
New investigation results, 'Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax,' are detailed in a study published in The Journal of General Virology. According to recent research published in the Journal of General Virology, "The antibody responses elicited by immunization of humans with vaccinia virus (VACV) strains Lister, Dryvax and NYVAC have been determined and compared. Neutralizing antibodies against intracellular mature virus (IMV) and extracellular enveloped virus (EEV), and binding antibody titres (ELISA) against the EEV protein B5, the IMV proteins A27 and H3, and...
Source: Vaccine Weekly (2009-01-07)
|
